Become a Founder Member Now!

Nevada mandates health insurance coverage for BRCA gene screening and testing

April 24, 2025 | House Bills - Introduced, House Bills, 2025 House and Senate Bills, Nevada Legislation Bills, Nevada


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Nevada mandates health insurance coverage for BRCA gene screening and testing
The Nevada State Legislature has introduced Assembly Bill 522, a significant piece of legislation aimed at enhancing health insurance coverage for certain medical benefits. Introduced on April 24, 2025, the bill seeks to address critical issues surrounding access to healthcare services, particularly in relation to genetic testing and counseling for harmful mutations in the BRCA gene.

The primary purpose of Assembly Bill 522 is to prohibit health insurance providers from imposing barriers that could hinder patients from accessing necessary medical benefits. Key provisions of the bill include restrictions against requiring higher deductibles, copayments, or longer waiting periods for benefits related to genetic testing. Additionally, the bill forbids insurers from canceling policies or refusing coverage based solely on a person's use of these benefits. It also aims to prevent financial incentives that might discourage healthcare providers from offering necessary services.

Notably, the bill has sparked discussions among lawmakers and stakeholders regarding its implications for both patients and insurance companies. Supporters argue that it is essential for ensuring equitable access to vital health services, particularly for women at risk of breast and ovarian cancers. Critics, however, express concerns about the potential financial impact on insurance providers and the healthcare system as a whole.

The economic implications of Assembly Bill 522 could be substantial. By mandating coverage for genetic testing and counseling, the bill may lead to increased healthcare costs for insurers, which could, in turn, affect premium rates for consumers. However, proponents contend that early detection and preventive measures could ultimately reduce long-term healthcare costs by addressing health issues before they escalate.

As the bill progresses through the legislative process, its significance is becoming increasingly clear. Experts suggest that if passed, Assembly Bill 522 could set a precedent for similar legislation in other states, potentially reshaping the landscape of health insurance coverage across the nation. The bill is scheduled for further discussion in upcoming legislative sessions, where its future will be determined.

View Bill

This article is based on a bill currently being presented in the state government—explore the full text of the bill for a deeper understanding and compare it to the constitution

View Bill